PL358791A1 - Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu - Google Patents
Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionuInfo
- Publication number
- PL358791A1 PL358791A1 PL01358791A PL35879101A PL358791A1 PL 358791 A1 PL358791 A1 PL 358791A1 PL 01358791 A PL01358791 A PL 01358791A PL 35879101 A PL35879101 A PL 35879101A PL 358791 A1 PL358791 A1 PL 358791A1
- Authority
- PL
- Poland
- Prior art keywords
- phenoxyalkyl
- thiazolidinedione
- metformin
- pharmaceutical composition
- type derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0010362A FR2812547B1 (fr) | 2000-08-04 | 2000-08-04 | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL358791A1 true PL358791A1 (pl) | 2004-08-23 |
Family
ID=8853342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01358791A PL358791A1 (pl) | 2000-08-04 | 2001-07-24 | Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20040014797A1 (pl) |
| EP (1) | EP1305025A1 (pl) |
| JP (1) | JP2004505915A (pl) |
| KR (1) | KR20030019470A (pl) |
| CN (1) | CN1446090A (pl) |
| AR (1) | AR030309A1 (pl) |
| AU (1) | AU2001282010A1 (pl) |
| BR (1) | BR0112915A (pl) |
| CA (1) | CA2417883A1 (pl) |
| CZ (1) | CZ2003476A3 (pl) |
| EC (1) | ECSP034463A (pl) |
| FR (1) | FR2812547B1 (pl) |
| HU (1) | HUP0303684A2 (pl) |
| MX (1) | MXPA03000975A (pl) |
| NO (1) | NO20030518D0 (pl) |
| PL (1) | PL358791A1 (pl) |
| RU (1) | RU2003105809A (pl) |
| SK (1) | SK2082003A3 (pl) |
| WO (1) | WO2002011721A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100897890B1 (ko) | 2002-06-17 | 2009-05-18 | 인벤티아 헬스케어 피브이티. 엘티디. | 티아졸리딘디온 및 바이구아나이드를 함유하는 다층 정제및 그의 제조 방법 |
| UA80991C2 (en) * | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
| AU2007281433A1 (en) * | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Compositions for intranasal delivery of human insulin and uses thereof |
| CN105152983A (zh) | 2007-01-29 | 2015-12-16 | 韩诺生物制药株式会社 | N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2749583B1 (fr) * | 1996-06-07 | 1998-08-21 | Lipha | Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
| BR9810172A (pt) * | 1997-06-18 | 2000-08-08 | Smithkline Beecham Plc | Tratamento de diabete com tiazolidinadiona e metformina |
| GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
-
2000
- 2000-08-04 FR FR0010362A patent/FR2812547B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-24 WO PCT/EP2001/008512 patent/WO2002011721A1/en not_active Application Discontinuation
- 2001-07-24 EP EP01960539A patent/EP1305025A1/en not_active Withdrawn
- 2001-07-24 HU HU0303684A patent/HUP0303684A2/hu unknown
- 2001-07-24 CN CN01813685A patent/CN1446090A/zh active Pending
- 2001-07-24 RU RU2003105809/15A patent/RU2003105809A/ru not_active Application Discontinuation
- 2001-07-24 KR KR1020027018026A patent/KR20030019470A/ko not_active Application Discontinuation
- 2001-07-24 JP JP2002517057A patent/JP2004505915A/ja active Pending
- 2001-07-24 CA CA002417883A patent/CA2417883A1/en not_active Abandoned
- 2001-07-24 AU AU2001282010A patent/AU2001282010A1/en not_active Abandoned
- 2001-07-24 BR BR0112915-5A patent/BR0112915A/pt not_active Application Discontinuation
- 2001-07-24 PL PL01358791A patent/PL358791A1/pl unknown
- 2001-07-24 MX MXPA03000975A patent/MXPA03000975A/es unknown
- 2001-07-24 US US10/343,609 patent/US20040014797A1/en not_active Abandoned
- 2001-07-24 SK SK208-2003A patent/SK2082003A3/sk unknown
- 2001-07-24 CZ CZ2003476A patent/CZ2003476A3/cs unknown
- 2001-08-03 AR ARP010103708A patent/AR030309A1/es unknown
-
2003
- 2003-02-03 NO NO20030518A patent/NO20030518D0/no not_active Application Discontinuation
- 2003-02-03 EC EC2003004463A patent/ECSP034463A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2417883A1 (en) | 2002-02-14 |
| MXPA03000975A (es) | 2003-06-09 |
| HUP0303684A2 (hu) | 2004-03-01 |
| CN1446090A (zh) | 2003-10-01 |
| FR2812547B1 (fr) | 2002-10-31 |
| KR20030019470A (ko) | 2003-03-06 |
| SK2082003A3 (en) | 2003-07-01 |
| WO2002011721A1 (en) | 2002-02-14 |
| AU2001282010A1 (en) | 2002-02-18 |
| ECSP034463A (es) | 2003-03-31 |
| BR0112915A (pt) | 2003-07-08 |
| EP1305025A1 (en) | 2003-05-02 |
| CZ2003476A3 (cs) | 2003-06-18 |
| US20040014797A1 (en) | 2004-01-22 |
| JP2004505915A (ja) | 2004-02-26 |
| AR030309A1 (es) | 2003-08-20 |
| RU2003105809A (ru) | 2004-08-27 |
| NO20030518L (no) | 2003-02-03 |
| FR2812547A1 (fr) | 2002-02-08 |
| NO20030518D0 (no) | 2003-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200203368B (en) | Pharmaceutical composition comprising a combination of metformin and glibenclamide. | |
| IL213240A (en) | Pharmacy composition containing poly-fluorescein conjugate | |
| EG24357A (en) | New Pharmaceutical composition | |
| IL152659A0 (en) | Pharmaceutical composition | |
| HK1075889A1 (en) | Pharmaceutical composition | |
| HUP0204555A3 (en) | Pharmaceutical composition | |
| GB0009605D0 (en) | Medicaments | |
| GB0025473D0 (en) | Pharmaceutical combinations | |
| GB0002312D0 (en) | Medicaments | |
| IL154238A0 (en) | Pharmaceutical composition | |
| GB0024362D0 (en) | Medicaments | |
| PL358791A1 (pl) | Kompozycja farmaceutyczna zawierająca metforminę i pochodną typu 5-fenoksyalkilo-2,4-tiazolidynodionu | |
| GB0015324D0 (en) | Medicaments | |
| ZA200109677B (en) | A nutritional and pharmaceutical composition. | |
| GB0005382D0 (en) | Pharmaceutical composition | |
| GB0021487D0 (en) | Pharmaceutical | |
| GB0101094D0 (en) | Pharmaceutical composition | |
| GB0002691D0 (en) | Pharmaceutical composition | |
| AUPQ875300A0 (en) | A pharmaceutical composition | |
| GB0023922D0 (en) | Medicaments | |
| GB0022155D0 (en) | Medicaments | |
| HU0000918D0 (en) | Medicaments | |
| GB0022156D0 (en) | Medicaments | |
| GB0009046D0 (en) | Medicaments | |
| GB0015851D0 (en) | Medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |